Skip to main content
. Author manuscript; available in PMC: 2016 May 1.
Published in final edited form as: Ann Surg Oncol. 2014 Aug 14;22(5):1634–1638. doi: 10.1245/s10434-014-3987-9

TABLE 1.

Patient characteristics

Characteristics No hepatic involvement (n = 875) Hepatic involvement (n = 99) p value
Female, n (%) 461 (52.7) 59 (59.6) 0.20
Age, mean (SD) years 52.7 (12.4) 53.8 (12.6) 0.42
Diabetes, n (%) 85 (10.2) 6 (6.3) 0.28
Heart disease, n (%) 71 (8.5) 8 (8.4) 1.00
Lung disease, n (%) 30 (3.6) 6 (6.3) 0.25
Any smoking history, n (%) 260 (31.9) 31 (33.0) 0.82
Body mass index, mean (SD) 27.7 (6.0) 27.5 (6.0) 0.58
Albumin, mean (SD) 3.7 (0.59) 3.7 (0.62) 0.88
ECOG performance status 0.38
 0/1 724 (83.9) 86 (87.8)
 2+ 139 (16.1) 12 (12.2)
Type of primary, n (%) 0.003
 Appendiceal 425 (48.7) 27 (32.9)
 Colorectal 201 (23.0) 32 (39.02)
 Mesothelioma 65 (7.5) 4 (4.9)
 Ovarian 63 (7.2) 4 (4.9)
 Gastric 42 (4.8) 2 (2.4)
 Other 77 (8.8) 13 (15.9)
Complete resection, n (%) (n = 952) 397 (45.7) 35 (42.2) 0.57

HI hepatic involvement, SD standard deviation, ECOG Eastern Cooperative Oncology Group